Vitrolife AB (publ) hereby invites analysts, investors, shareholders and journalists to a Capital Markets Day on November 11.
We will talk about Vitrolife’s business, which assists in making many people’s desire to have children a reality. During 2012 Vitrolife contributed to the birth of an estimated 70,000 children. We will give an update on the operative and financial development of the Vitrolife Group and look deeper into the future of the IVF field. There will be an opportunity to visit one of our production facilities and to see how some of our most important products are used.
November 11, 4 pm – 7 pm.
Vitrolife’s headquarters, Gustaf Werners gata 2, 421 32 Västra Frölunda/Gothenburg.
Please inform Anita Ahlqvist that you will attend by email, email@example.com, or by telephone on +46 (0)31–721 80 83, no later than October 30. A light meal will be served, so please inform us of any allergies you may have. There is a limited number of places. For the full program, please visit www.vitrolife.com. The presentation will be held in Swedish.
Gothenburg, October 8, 2013
VITROLIFE AB (publ)
Queries should be addressed to:
Thomas Axelsson, CEO, tel 46 31 721 80 01
Mikael Engblom, CFO, tel 46 31 721 80 14
Vitrolife is required to publish the information in this press release in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on October 8, 2013 at 08:30 a.m.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.